Oxycodone Test Evidence
Has Caused a False Positive
Naloxone
2 sources Jenkins et al., Clin Chem 2009 Gall and El-Khoury, Clin Chem 2019
What It Found
- Naloxone can cross-react with certain oxycodone tests, including during investigation of samples from people receiving buprenorphine/naloxone.
Test Studied
- Selected oxycodone-specific urine immunoassays
Source Smid et al., O G Open 2026
Keep in Mind
- This is distinct from detecting the shared metabolite noroxymorphone on targeted mass spectrometry.
All 3 sources Jenkins et al., Clin Chem 2009 Gall and El-Khoury, Clin Chem 2019 Smid et al., O G Open 2026
Keep in Mind
- The formulation alone cannot account for every positive.
- Suboxone contains both naloxone and buprenorphine.
Naltrexone
2 sources Beauregard and Maguire, Ment Health Clin 2024 Majumdar and Chatterjee, Asian J Psychiatr 2024
What It Found
- Oral naltrexone was associated with repeated unexpected oxycodone screens.
Test Studied
- Oxycodone-specific urine immunoassays
2 sources Beauregard and Maguire, Ment Health Clin 2024 Stanciu and Gnanasegaram, J Psychoactive Drugs 2020
What It Found
- Detailed testing identified noroxymorphone, a minor naltrexone metabolite also formed downstream from oxycodone.
Keep in Mind
- An isolated shared metabolite should be interpreted alongside the parent compounds and the full medication history.
Test Studied
- Follow-up drug/metabolite testing
All 3 sources Beauregard and Maguire, Ment Health Clin 2024 Majumdar and Chatterjee, Asian J Psychiatr 2024 Stanciu and Gnanasegaram, J Psychoactive Drugs 2020
Keep in Mind
- These reports concern oral naltrexone.
Depends on the Brand of Test
Codeine
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI interference from Codeine.
- Codeine or hydrocodone was present in most specimens with a false-positive or indeterminate Monitect POC result.
Keep in Mind
- The POC observation did not isolate the causal drug.
- It should not be used to attribute an individual patient result to Codeine.
Test Studied
- Microgenics DRI on Bayer ADVIA 1650 and Branan Monitect POC, 100 ng/mL oxycodone cutoff
Source Backer et al., J Anal Toxicol 2005
What It Found
- Patient urine with Codeine above 75,000 ng/mL could remain negative on this oxycodone-specific assay.
Keep in Mind
- A negative comparator is specific to the DRI assay.
- A general opiates screen targets different compounds.
Test Studied
- DRI Oxycodone enzyme immunoassay, 100 ng/mL cutoff, with GC-MS
Hydrocodone
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI interference from Hydrocodone.
- Codeine or hydrocodone was present in most specimens with a false-positive or indeterminate Monitect POC result.
Keep in Mind
- The POC observation did not isolate the causal drug.
- It should not be used to attribute an individual patient result to Hydrocodone.
Test Studied
- Microgenics DRI on Bayer ADVIA 1650 and Branan Monitect POC, 100 ng/mL oxycodone cutoff
Source Backer et al., J Anal Toxicol 2005
What It Found
- Patient urine with Hydrocodone above 75,000 ng/mL could remain negative on this oxycodone-specific assay.
Keep in Mind
- A negative comparator is specific to the DRI assay.
- A general opiates screen targets different compounds.
Test Studied
- DRI Oxycodone enzyme immunoassay, 100 ng/mL cutoff, with GC-MS
The Test Is Made to Find It
Oxycodone
2 sources Gingras et al., J Anal Toxicol 2010 Stolbach et al., J Med Toxicol 2022
What It Found
- Oxycodone and its metabolite oxymorphone are targets of commonly used dedicated oxycodone screens.
Keep in Mind
- The presence of the prescribed drug is analytically expected.
Source Haller et al., J Anal Toxicol 2006
What It Found
- Two oxycodone screen-positive urines containing less than 50 ng/mL free oxycodone contained oxymorphone and oxycodone glucuronide above 100 ng/mL.
Keep in Mind
- Confirmation must cover appropriate metabolites when free parent drug has decreased.
Source Heltsley et al., J Anal Toxicol 2010
What It Found
- Urines containing only noroxycodone were best detected by the oxycodone EIA in this pain-clinic comparison.
Keep in Mind
- Noroxycodone is an actual oxycodone metabolite.
- Other platforms can respond differently.
Test Studied
- Oxycodone urine ELISA and EIA compared with LC-MS/MS
Source Stolbach et al., J Med Toxicol 2022
Keep in Mind
- Urine concentration alone cannot identify dose or impairment.
3 sources Gingras et al., J Anal Toxicol 2010 Stolbach et al., J Med Toxicol 2022 Haller et al., J Anal Toxicol 2006
Test Studied
- Oxycodone-specific urine immunoassay and GC-MS
2 sources Gingras et al., J Anal Toxicol 2010 Haller et al., J Anal Toxicol 2006
Test Studied
- Microgenics DRI oxycodone and GC-MS confirmation
Oxymorphone
Source Gingras et al., J Anal Toxicol 2010
What It Found
- This oxycodone assay was designed to recognize oxymorphone as well.
Test Studied
- DRI oxycodone urine immunoassay
Both sources Gingras et al., J Anal Toxicol 2010 Stolbach et al., J Med Toxicol 2022
What It Found
- A person taking oxymorphone may have a positive oxycodone-class screen.
Keep in Mind
- Whether the result represents prescribed oxymorphone or oxycodone metabolism requires specific analytes and medication history.
Suspected, but Not Proven
Hydroxychloroquine
Source Radke et al., Toxicol Rep 2019
What It Found
- After a large overdose, the urine sample caused an absorbance alarm on the oxycodone screen.
- Spiking showed that high levels could affect several urine assays.
Keep in Mind
- An instrument alarm is an uninterpretable result, not a demonstrated positive oxycodone screen.
Test Studied
- Enzyme immunoassay for oxycodone
Tested: No False Positive Found
Hydromorphone
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI oxycodone interference from Hydromorphone.
Keep in Mind
- The result applies to the tested DRI method.
- The abstract does not specify a comparator spike concentration.
Test Studied
- Microgenics DRI oxycodone test on a Bayer ADVIA 1650, cutoff 100 ng/mL
Source Backer et al., J Anal Toxicol 2005
What It Found
- Patient urine with Hydromorphone above 12,000 ng/mL could remain negative on this oxycodone-specific assay.
Keep in Mind
- A negative comparator is specific to the DRI assay.
- A general opiates screen targets different compounds.
Test Studied
- DRI Oxycodone enzyme immunoassay, 100 ng/mL cutoff, with GC-MS
Morphine
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI oxycodone interference from Morphine.
Keep in Mind
- The result applies to the tested DRI method.
- The abstract does not specify a comparator spike concentration.
Test Studied
- Microgenics DRI oxycodone test on a Bayer ADVIA 1650, cutoff 100 ng/mL
Source Backer et al., J Anal Toxicol 2005
What It Found
- Patient urine with Morphine above 163,000 ng/mL could remain negative on this oxycodone-specific assay.
Keep in Mind
- A negative comparator is specific to the DRI assay.
- A general opiates screen targets different compounds.
Test Studied
- DRI Oxycodone enzyme immunoassay, 100 ng/mL cutoff, with GC-MS
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Dihydrocodeine
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI oxycodone interference from Dihydrocodeine.
Keep in Mind
- The result applies to the tested DRI method.
- The abstract does not specify a comparator spike concentration.
Test Studied
- Microgenics DRI oxycodone test on a Bayer ADVIA 1650, cutoff 100 ng/mL
Diphenhydramine
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Heroin
Source Haller et al., J Anal Toxicol 2006
What It Found
- The authors found no DRI oxycodone interference from 6-monoacetylmorphine, the heroin metabolite.
Keep in Mind
- Only the heroin metabolite 6-acetylmorphine (6-MAM) was tested.
- The experiment gives no direct result for the parent drug.
- The abstract does not give the challenge concentration.
Test Studied
- Microgenics DRI oxycodone test on a Bayer ADVIA 1650, cutoff 100 ng/mL
Levofloxacin
Source Colby et al., Clin Biochem 2019
What It Found
- Levofloxacin did not cross-react with the oxycodone assay in the same study in which it reacted with the morphine-class opiate and buprenorphine reagents.
Keep in Mind
- The negative finding is specific to the assay and concentrations studied.
Test Studied
- Abbott MULTIGENT oxycodone
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels